{
  "schemaVersion" : 2,
  "registerId" : "F2011L01442",
  "instrumentNumber" : "85/2011",
  "citation" : "Statement of Principles concerning acute pancreatitis No. 85 of 2011",
  "conditionName" : "acute pancreatitis",
  "effectiveFrom" : "2011-07-13",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "K85"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "having cholelithiasis at the time of the clinical onset of acute\r\npancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(b)",
    "text" : "having biliary microlithiasis or biliary sludge at the time of the clinical\r\nonset of acute pancreatitis",
    "definedTerms" : [ {
      "term" : "biliary microlithiasis or biliary sludge",
      "definition" : "means the presence of small stones\n(1-2 mm) due to aggregation of bile constituents into a stone or calculus or a\ncollection of crystals, glycoproteins, protein, cellular debris and mucin in the\nbiliary tract"
    } ]
  }, {
    "paragraph" : "6(c)",
    "text" : "drinking at least 36 kilograms of alcohol within any two year period,\r\nand continuing to consume alcohol at the time of the clinical onset of\r\nacute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(d)",
    "text" : "having an acute infection with an organism from the specified list at the\r\ntime of the clinical onset of acute pancreatitis",
    "definedTerms" : [ {
      "term" : "acute infection with an organism from the specified list",
      "definition" : "means\nserological and/or clinical evidence of acute infection with one or more of the\nfollowing:\n(a) coxsackievirus;\n(b) Cryptosporidium;\n(c) cytomegalovirus;\n(d) Epstein-Barr virus;\n(e) hepatitis A virus;\n(f) hepatitis B virus;\n(g) hepatitis C virus;\n(h) hepatitis E virus;\n(i) herpes simplex virus;\n(j) Legionella spp;\n(k) Leptospira spp;\n(l) measles virus;\n(m) mumps virus;\n(n) Mycobacterium avium;\n(o) Mycobacterium tuberculosis;\n(p) Mycoplasma pneumoniae;\n(q) Salmonella enterica;\n(r) Salmonella bongori; or\n(s) varicella-zoster virus"
    } ]
  }, {
    "paragraph" : "6(e)",
    "text" : "having ascariasis or clonorchiasis at the time of the clinical onset of\r\nacute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(f)",
    "text" : "being infected with human immunodeficiency virus at the time of the\r\nclinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(g)",
    "text" : "having pancreatic outflow obstruction due to a disorder from the\r\nspecified list at the time of the clinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(h)",
    "text" : "being treated with a drug from the specified table at the time of the\r\nclinical onset of acute pancreatitis",
    "definedTerms" : [ {
      "term" : "being treated with a drug from the specified table",
      "definition" : "means being treated\nwith any drug listed in column 2 of the following table:\nClass Drug\nCardiovascular\nACE inhibitors Captopril, enalapril, lisinopril, ramipril\nAngiotensin receptor Losartan\nblockers\nCentrally acting agents Methyldopa\nLoop diuretics Furosemide\nThiazide diuretics Chlorothiazide, hydrochlorothiazide\nAnti-arrhythmics Amiodarone\nHMG-CoA reductase Simvastatin, pravastatin, fluvastatin\ninhibitors\nOther cholesterol Bezafibrate\nlowering drugs\nAntimicrobial\nAntibacterials Tetracycline, metronidazole, dapsone, cotrimoxazole,\nnitrofurantoin, clarithromycin, erythromycin\nAntituberculars Isoniazid\nAntivirals Nelfinavir, lamivudine, didanosine, interferon/ribavirin\nOthers Pentamidine, sodium stibogluconate, meglumine\nantimonite\nGastrointestinal\nAcid suppressants Cimetidine, ranitidine, omeprazole\nIBD drugs Azathioprine, mercaptopurine, mesalamine, olsalazine,\nsulphasalazine\nNeuropsychiatric\nAnticonvulsants Valproic acid\nAntipsychotics Clozapine\nHormone-related\nOestrogens Conjugated oestrogen, clomifene, premarin, tamoxifen\nAnti-thyroid agents Thimazole, carbimazole\nOncological\nAlkylating agents Ifosfamide\nAntimetabolites Cytarabine\nOther Asparaginase\nAnalgesic\nOpioids Codeine\nNSAIDs Sulindac, naproxen, ketoprofen\nOther Marijuana, isotretinoin, pyritinol, IV or oral\ncorticosteroid, propofol"
    } ]
  }, {
    "paragraph" : "6(i)",
    "text" : "being treated with a drug which is associated in the individual with:\r\n(i) the development of the symptoms or signs of acute pancreatitis\r\nwithin two months of commencing drug therapy; and\r\n(ii) the cessation of the symptoms or signs of acute pancreatitis\r\nwithin weeks of discontinuing drug therapy; and\r\n(iii) an absence of clinical or laboratory evidence of acute\r\npancreatitis prior to beginning drug therapy; and\r\nwhere treatment with the drug continued for at least the three days\r\nbefore the clinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(j)",
    "text" : "smoking at least 15 pack-years of cigarettes or the equivalent thereof in\r\nother tobacco products, before the clinical onset of acute pancreatitis,\r\nand where smoking has ceased, the clinical onset has occurred within\r\nten years of cessation",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(k)",
    "text" : "undergoing intra-abdominal or intrathoracic surgery within the 30 days\r\nbefore the clinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(l)",
    "text" : "undergoing solid organ transplantation before the clinical onset of acute\r\npancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(m)",
    "text" : "having penetrating or major blunt trauma to the upper abdomen within\r\nthe seven days before the clinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(n)",
    "text" : "undergoing endoscopic retrograde cholangio-pancreatography,\r\nendoscopic sphincterotomy of the sphincter of Oddi or manometry of\r\nthe sphincter of Oddi within the seven days before the clinical onset of\r\nacute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(o)",
    "text" : "having hypertriglyceridaemia resulting in triglyceride levels above\r\n1000 milligrams per decilitre (or 11.3 millimoles per litre) at the time\r\nof the clinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(p)",
    "text" : "having hypercalcaemia at the time of the clinical onset of acute\r\npancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(q)",
    "text" : "having a disease from the specified list at the time of the clinical onset\r\nof acute pancreatitis",
    "definedTerms" : [ {
      "term" : "a disease from the specified list",
      "definition" : "means:\n(a) Henoch-Sch√∂nlein purpura;\n(b) inflammatory bowel disease;\n(c) microangiopathic haemolytic anaemia;\n(d) microscopic polyangiitis;\n(e) polyarteritis nodosa; or\n(f) systemic lupus erythematosus"
    } ]
  }, {
    "paragraph" : "6(r)",
    "text" : "envenomation by a snake or scorpion from the specified list within the\r\nseven days before the clinical onset of acute pancreatitis",
    "definedTerms" : [ {
      "term" : "a snake or scorpion from the specified list",
      "definition" : "means:\n(a) Cerastes cerastes;\n(b) Tityus asthenes;\n(c) Tityus trinitatis; or\n(d) Viperidae family"
    } ]
  }, {
    "paragraph" : "6(s)",
    "text" : "having acute toxicity after oral ingestion of mushrooms containing\r\nalpha-amanitin within the seven days before the clinical onset of acute\r\npancreatitis",
    "definedTerms" : [ {
      "term" : "alpha-amanitin",
      "definition" : "means the cyclopeptide toxin present in some mushrooms\nsuch as Amanita phalloides which produces amanita poisoning"
    } ]
  }, {
    "paragraph" : "6(t)",
    "text" : "ingesting an agent from the specified list and experiencing acute\r\ntoxicity within the seven days before the clinical onset of acute\r\npancreatitis",
    "definedTerms" : [ {
      "term" : "an agent from the specified list",
      "definition" : "means:\n(a) carbamate insecticide;\n(b) methyl alcohol;\n(c) organophosphorous insecticide; or\n(d) paracetamol in overdose"
    } ]
  }, {
    "paragraph" : "6(u)",
    "text" : "having a disorder resulting in disseminated intravascular coagulation\r\nand/or profound systemic hypotension with pancreatic acinar damage\r\nwithin the seven days before the clinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(v)",
    "text" : "having a course of peritoneal dialysis for renal disease at the time of the\r\nclinical onset of acute pancreatitis",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(w)",
    "text" : "inability to obtain appropriate clinical management for acute\r\npancreatitis",
    "definedTerms" : [ ]
  } ]
}